Provectus Biopharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 2/6
Provectus Biopharmaceuticals has a total shareholder equity of $-7.5M and total debt of $3.0M, which brings its debt-to-equity ratio to -39.9%. Its total assets and total liabilities are $856.4K and $8.4M respectively.
주요 정보
-39.9%
부채 비율
US$3.00m
부채
| 이자 보상 비율 | n/a |
| 현금 | US$29.58k |
| 주식 | -US$7.51m |
| 총 부채 | US$8.37m |
| 총 자산 | US$856.43k |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
재무 상태 분석
단기부채: PVCT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: PVCT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: PVCT has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: PVCT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: PVCT has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
예측 현금 활주로: PVCT is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.